2 ASX giants to buy and hold for the next 20 years

Looking for the best shares to buy and hold? Here are two blue chips to consider.

| More on:
A young well-dressed couple at a luxury resort celebrate successful life choices.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • CSL stands as a beacon of resilience and growth in global healthcare, leveraging ageing demographics and rising healthcare needs to continually invest in research and expand its product offerings, promising long-term value for patient investors.
  • Goodman Group capitalises on the surging demand for industrial and logistics spaces crucial for e-commerce and AI, backed by strategic partnerships like its recent A$14 billion European data centre project with the Canada Pension Plan Investment Board.
  • Both CSL and Goodman offer compelling investment cases with their sustainable advantages and expansive market reach, poised to benefit from long-term trends in healthcare and digital infrastructure over the next two decades.

Trying to predict what the share market will do next week, next month, and next year is hard enough. Trying to forecast the next two decades can feel impossible.

That's why long-term investing is often about identifying businesses with sustainable advantages, massive addressable markets, and management teams that know how to compound value over time. If you get those elements right, short-term volatility becomes little more than background noise.

With that in mind, here are two ASX giants that I believe have the qualities required to still be thriving and potentially much larger 20 years from now.

CSL Ltd (ASX: CSL)

CSL might have been out of form in 2025, but it remains one of Australia's greatest corporate success stories and its long-term investment case remains compelling.

The company sits at the centre of global healthcare, specialising in plasma-derived therapies, vaccines, and biotechnology. Demand for CSL's products is driven by powerful structural trends, including ageing populations, improving diagnosis rates, and rising healthcare spending across developed and emerging markets.

What makes CSL especially attractive for long-term investors is its ability to reinvest heavily while still generating strong cash flows. The company consistently pours billions into research and development, facilities, and acquisitions to strengthen its pipeline and widen its moat. Importantly, these investments are designed to deliver returns over decades, not quarters.

While CSL's share price can go through periods of consolidation or weakness, such as in 2025, its underlying business has proven remarkably resilient across economic cycles. Over a 20-year timeframe, that consistency, combined with compounding earnings growth, is exactly what patient investors should be looking for. So, with its shares down heavily over the past 12 months, I think now could be an opportune time to make a long-term investment.

Goodman Group (ASX: GMG)

Goodman Group may be classified as a property stock, but it operates very differently to traditional real estate businesses.

Rather than shopping centres or offices, this ASX giant focuses on high-quality industrial property, logistics hubs, and data-enabled warehouses. These assets sit at the heart of global supply chains and are critical infrastructure for e-commerce, automation, and artificial intelligence.

Goodman's edge comes from its development expertise and global footprint. It works closely with major customers to design and build customised facilities, locking in long-term relationships while earning development profits and recurring rental income. This capital-light model has allowed the company to grow rapidly without overloading its balance sheet.

An example of this is the agreement it signed with the Canada Pension Plan Investment Board this month. This will see it establish a A$14 billion European data centre partnership comprising four projects totalling 435 MW of primary power and 282 MW of IT load.

Looking ahead, the growth of online retail, cloud computing, and AI-driven logistics should keep demand for Goodman's assets strong for many years. Its exposure to data centres adds another long runway, as digital infrastructure becomes as essential as roads and ports.

Motley Fool contributor James Mickleboro has positions in CSL and Goodman Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Goodman Group. The Motley Fool Australia has recommended CSL and Goodman Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

A man and woman sit next to each other looking at each other and feeling excited and surprised after reading good news about their shares on a laptop.
Blue Chip Shares

3 Australian shares with bullish catalysts heading into 2026

Not all ASX shares are equal in 2026. These three have catalysts that could move the needle.

Read more »

Cheerful boyfriend showing mobile phone to girlfriend in dining room. They are spending leisure time together at home and planning their financial future.
Blue Chip Shares

Where to invest $10,000 into ASX 200 shares in January 2026

Brokers think these shares are top picks for investors next month.

Read more »

A man with his back to the camera holds his hands to his head as he looks to a jagged red line trending sharply downward representing the ASX tech share sell-off today
Blue Chip Shares

The ASX blue chip shares I'd buy during the next correction

In the share market, it can pay to hope for the best but prepare for the worst.

Read more »

Buy, hold, and sell ratings written on signs on a wooden pole.
Blue Chip Shares

Is now the time to buy Wesfarmers shares?

Wesfarmers shares have traded sideways recently. Is this a buying opportunity or simply fair value?

Read more »

A group of six young people doing the limbo on a beach, indicating oversold shares that can not go any lower.
Share Fallers

Down over 40% this year, could these 3 ASX shares bounce back in 2026?

After a brutal 2025, these 3 ASX shares have been heavily sold off and could be worth watching for a…

Read more »

Excited couple celebrating success while looking at smartphone.
Blue Chip Shares

3 no-brainer ASX 200 shares to buy with $5,000

You don't need a brain to see that these shares could be quality investments.

Read more »

Three young people lie in the surf on a beach wearing santa hats.
Blue Chip Shares

BHP, Macquarie, and Westpac: Naughty or nice? 3 popular ASX shares examined

Let's see if these blue chips made their shareholders smile in 2025.

Read more »

Two men laughing while bouncing on bouncy balls
Blue Chip Shares

I think these ASX blue chips shares are primed for a major rebound in 2026

2025 was not kind to these shares. Here's why things could be better next year.

Read more »